Improving TB and HIV treatment adherence through peer-led education in Uganda
Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda
This study is looking to help people in Uganda who are being treated for tuberculosis (TB) and HIV by training peers who have gone through TB treatment to offer support and guidance, making it easier for patients to stick to their treatment plans and improve their health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11009333 on NIH RePORTER |
What this research studies
This research focuses on enhancing treatment adherence for tuberculosis (TB) and HIV among individuals in Uganda by implementing a peer-led education and counseling program. The approach involves training peers who have experienced TB to provide support and guidance to others undergoing treatment, addressing barriers to adherence. The study will evaluate the effectiveness of this peer-navigation strategy across multiple clinics, aiming to improve both TB literacy and treatment outcomes for patients. By restructuring clinic workflows and utilizing behavior-change messaging, the research seeks to create a supportive environment for patients dealing with TB and HIV.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals aged 21 and older who are newly diagnosed with tuberculosis, particularly those co-infected with HIV.
Not a fit: Patients who are not newly diagnosed with TB or who do not have access to the participating clinics in Uganda may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve treatment adherence and health outcomes for patients with TB and HIV in Uganda.
How similar studies have performed: Previous research has shown success with peer-led interventions in HIV treatment adherence, suggesting a promising approach for TB as well.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Davis, John Lucian — Yale University
- Study coordinator: Davis, John Lucian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.